Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials.

Ilaria DicembriniBesmir NreuEdoardo MannucciMatteo Monami

Published in: Diabetes, obesity & metabolism (2019)

Available data from randomized trials do not suggest a detrimental effect of SGLT-2is on the incidence of malignancies in general, or in bladder cancer in particular.

Keyphrases

papillary thyroid
systematic review
squamous cell
risk factors
electronic health record
big data
lymph node metastasis
squamous cell carcinoma
childhood cancer
young adults
artificial intelligence